title: Weekly fluconazole for the suppression of recurrent thrush in HIV-seropositive patients: impact on the incidence of disseminated cryptococcal infection.
authors.forename: J A
authors.initials: JA
authors.lastname: Newton
authors.forename: S A
authors.initials: SA
authors.lastname: Tasker
authors.forename: W D
authors.initials: WD
authors.lastname: Bone
authors.forename: E C
authors.initials: EC
authors.lastname: Oldfield
authors.forename: P E
authors.initials: PE
authors.lastname: Olson
authors.forename: M T
authors.initials: MT
authors.lastname: Nguyen
authors.forename: M R
authors.initials: MR
authors.lastname: Wallace
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage*; D002180:Candidiasis, Oral / Q000188:drug therapy* / Q000209:etiology; D003453:Cryptococcosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D015725:Fluconazole / Q000008:administration & dosage*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D012008:Recurrence
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole